ArticleCancers2023

Phase 1 Study to Evaluate the Safety of Reducing the Prophylactic Dose of Dexamethasone around Docetaxel Infusion in Patients with Prostate and Breast Cancer.

Rieneke T Lugtenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.